A5002410509- Lung Cancer Treatments and Mutations
- Cardiac electrophysiology and arrhythmias
- Chemotherapy-induced cardiotoxicity and mitigation
- Receptor Mechanisms and Signaling
- ECG Monitoring and Analysis
- HER2/EGFR in Cancer Research
John T. Mather Memorial Hospital
2017-2021
Aim: To evaluate the prevalence and longitudinal changes of prolonged QTc in DM patients admitted to our community hospital, determine, if any, its correlation with left ventricular ejection fraction (LVEF). Methods: A retrospective chart review Type 1 (T1DM) 2 (T2DM) at least two admissions during a four-year period was performed identify interval, LVEF, as measured on transthoracic echocardiogram. Changes LVEF between patient hospital were compared. Results: interval found 66.7% (n = 24)...
Objective: To assess the prevalence of QTc prolongation in both non-diabetic and diabetic patients on TKIs. Some TKIs have been reported to cause prolongation, which is prevalent diabetes. However, there no Risk Evaluation Mitigation Strategy using series ECG monitor those patients. Methods: Patients taking TKIs, with two ECGs recorded between 1 January 2010 31 December 2017 were selected from electronic database. The duration >450 ms was determined as prolonged. Percentage participants...